Nisa Investment Advisors’s Day One Biopharmaceuticals DAWN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.8K | Buy |
1,046
+46
| +5% | +$299 | ﹤0.01% | 2391 |
|
|
2025
Q1 | $7.93K | Sell |
1,000
-52
| -5% | -$412 | ﹤0.01% | 2156 |
|
|
2024
Q4 | $13.3K | Sell |
1,052
-42
| -4% | -$532 | ﹤0.01% | 2059 |
|
|
2024
Q3 | $15.2K | Sell |
1,094
-63
| -5% | -$878 | ﹤0.01% | 1992 |
|
|
2024
Q2 | $15.9K | Buy |
1,157
+1,063
| +1,131% | +$14.6K | ﹤0.01% | 2019 |
|
|
2024
Q1 | $1.55K | Buy |
94
+69
| +276% | +$1.14K | ﹤0.01% | 2281 |
|
|
2023
Q4 | $365 | Sell |
25
-762
| -97% | -$11.1K | ﹤0.01% | 2468 |
|
|
2023
Q3 | $9.66K | Buy |
787
+741
| +1,611% | +$9.09K | ﹤0.01% | 2183 |
|
|
2023
Q2 | $549 | Buy |
46
+16
| +53% | +$191 | ﹤0.01% | 2540 |
|
|
2023
Q1 | $0 | Hold |
30
| – | – | ﹤0.01% | 2566 |
|
|
2022
Q4 | $1K | Buy |
+30
| New | +$1K | ﹤0.01% | 2417 |
|